[BRIEFING.COM] The S&P 500 (-0.1%), Nasdaq Composite (-0.5%), and DJIA (+0.2%) remain mostly lower, but off their worst levels of the session as strength broadens, leaving just the information technology sector (-1.4%) in negative territory.
Meanwhile, the health care sector (+2.3%) continues to lead the advance, with UnitedHealth (UNH 437.47, +18.95, +4.53%) trading sharply higher after delivering a much stronger-than-expected Q2 and lifting its FY26 adjusted EPS outlook to $19.50-$20.00 from prior guidance of greater than $18.25. Adjusted EPS of $6.38 beat consensus by roughly $1.50 on revenue of $112.03 billion, while management paired the numbers with a more constructive tone around execution, Medicare performance, and Optum trends. The key driver appears to be growing confidence that the company is converting pricing, care management, and operating discipline into a more durable earnings recovery, especially after investors had been focused on whether margin improvement was sustainable. The main offset is that not all cost pressures are easing: commercial medical cost trend remains stubbornly high and modestly above the prior ~11% expectation, while Medicaid margins are still expected to stay pressured.
UnitedHealth delivered the type of quarter investors had been waiting for following last year's sharp earnings reset. The combination of a decisive earnings beat, a much better-than-expected medical care ratio, and another sizeable guidance increase suggests the company's turnaround is progressing more quickly than expected. The upgraded FY26 outlook, better Medicare cost experience, and steadier Optum commentary all support the idea that 2026 can serve as a cleaner earnings base into 2027.